Download PDF
Semin Respir Crit Care Med 2001; 22(5): 551-558
DOI: 10.1055/s-2001-18427
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Chronic Allograft Rejection (Obliterative Bronchiolitis)

Geert M. Verleden
  • University Hospital Gasthuisberg, Department of Respiratory Medicine, Lung Transplantation Unit, Leuven, Belgium
Further Information

Publication History

Publication Date:
14 November 2001 (online)

    Permissions and Reprints

ABSTRACT

Lung and heart-lung transplantation are currently recognized as effective treatment for selected patients with end-stage lung or heart-lung disease. Although the survival rates have improved in recent years, long-term survival is still hampered by the development of chronic rejection. Histologically chronic rejection is manifested by obliterative bronchiolitis (OB), a process that leads to airways obstruction, with a gradual decline in pulmonary function tests. Extensive research efforts have attempted to unravel the pathophysiology of OB and identify key cytokines and growth factors involved in the process. Since the hisotological diagnosis of chronic rejection remains difficult, a clinical grading system has been proposed, determined as bronchiolitis obliterans syndrome (BOS), divided into four and, more recently, five categories, depending on the severity of airflow obstruction. This paper reviews the current knowledge of chronic rejection after heart-lung and lung transplantation.

KEYWORD

Chronic rejection - obliterative bronchiolitis - bronchiolitis obliterans syndrome

REFERENCES

  • 1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000.  J Heart Lung Transplant . 2000;  19 909-931
    CrossrefPubMedGoogle Scholar
  • 2 Cooper J D, Billingham M, Egan T. A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allografts.  J Heart Lung Transplant . 1993;  12 713-716
    PubMedGoogle Scholar
  • 3 Reichenspurner H, Girgis R E, Robbins B C. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.  Ann Thorac Surg . 1996;  62 1467-1472
    CrossrefPubMedGoogle Scholar
  • 4 Meyers B F, Lynch J, Trulock E P, Guthrie T J, Cooper J D, Patterson G A. Lung transplantation: a decade of experience.  Ann Surg . 1999;  230 362-370
    CrossrefPubMedGoogle Scholar
  • 5 Whitehead B, Rees P, Sorensen K. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.  J Heart Lung Transplant . 1993;  12 903-908
    PubMedGoogle Scholar
  • 6 Van Raemdonck D, Verleden G, Vanhaecke J. The current status of lung transplantation.  Acta Chir Austriaca . 1999;  31 292-301
    PubMedGoogle Scholar
  • 7 Tamm M, Sharples L, Higenbottam T, Steward S, Wallwork J. Bronchiolitis obliterans syndrome (BOS) following heart- lung transplantation.  Transpl Int . 1996;  9(suppl 1) S299-S302
    PubMedGoogle Scholar
  • 8 Kroshus T J, Kshettry V R, Savik K, Ranjit J, Hertz M I, Bolman R M. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.  J Thorac Cardiovasc Surg . 1997;  114 195-202
    CrossrefPubMedGoogle Scholar
  • 9 Stanbrook M B, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans.  Am J Respir Crit Care Med . 1999;  160 2034-2039
    PubMedGoogle Scholar
  • 10 Kshettry V R, Kroshus T J, Savik K, Hertz M I, Bolman R M. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients.  Chest . 1996;  110 704-709
    CrossrefPubMedGoogle Scholar
  • 11 Hirt S W, You X M, Moller F. Development of obliterative bronchiolitis after allogeneic lung transplantation: implication of acute rejection and the time point of treatment.  J Heart Lung Transplant . 1999;  18 542-548
    PubMedGoogle Scholar
  • 12 Bando K, Paradis I L, Similo S. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management.  J Thorac Cardiovasc Surg . 1995;  110 4-13
    CrossrefPubMedGoogle Scholar
  • 13 Husain A N, Siddique M T, Holmes E W. Analysis of risk factors for the development of bronchiolitis obliterans syndrome.  Am J Respir Crit Care Med . 1999;  159 829-833
    CrossrefPubMedGoogle Scholar
  • 14 Ross D J, Marchevsky A, Kramer M, Kass R M. ``Refractoriness'' of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.  J Heart Lung Transplant . 1997;  16 832-838
    PubMedGoogle Scholar
  • 15 Verleden G M. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.  Monaldi Arch Chest Dis . 2000;  55 140-145
    PubMedGoogle Scholar
  • 16 Quantz M A, Bennett L E, Meyer D M, Novick R J. Does human leukocyte antigen matching influence the outcome of lung transplantation?.  <~>An analysis of 3549 lung transplantations. J Heart Lung Transplant . 2000;  19 473-479
    CrossrefPubMedGoogle Scholar
  • 17 Schulan L L, Weinberg A D, McGregor C, Galantowicz M E, Suciu-Foca N M, Itescu S. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.  Am J Respir Crit Care Med . 1998;  157 1833-1837
    PubMedGoogle Scholar
  • 18 Smith M A, Sundaresan S, Mohanakumar T. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.  J Thorac Cardiovasc Surg . 1998;  116 812-820
    CrossrefPubMedGoogle Scholar
  • 19 Girgis R E, Tu I, Berry G J. Risk factors for the development of obliterative bronchiolitis after lung transplantation.  J Heart Lung Transplant . 1996;  15 1200-1208
    PubMedGoogle Scholar
  • 20 Soghikian M V, Valentine V G, Berry G J, Patel H R, Robbins R C, Theodore J. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.  J Heart Lung Transplant . 1996;  15 881-887
    PubMedGoogle Scholar
  • 21 Reichenspurner H, Soni V, Nitschke M. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.  J Heart Lung Transplant . 1998;  17 439-451
    PubMedGoogle Scholar
  • 22 Baudet E M, Dromer C, Dubrez J. Intermediate-term results after en bloc double-lung transplantatoin with bronchial arterial revascularisation.  J Thorac Cardiovas Surg . 1996;  112 1292-1299
    PubMedGoogle Scholar
  • 23 Yacoub M, Al-Kttan K M, Tadjkarimi S, Eren T, Khaghani A. Medium term results of direct bronchial arterial revascularization using IMA for single lung transplantation (SLT) with direct revascularisation.  Eur J Cardiothor Surg . 1997;  11 1030-1036
    PubMedGoogle Scholar
  • 24 Norgaard M A, Andersen C B, Pettersson G. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?.  Eur J Cardiothor Surg . 1998;  14 311-317
    PubMedGoogle Scholar
  • 25 Daly R C, McGregor C GA, McDougall J C, Midthun D E, Peters S G, Scott J P. Bronchial artery revascularization does not prevent bronchiolitis obliterans syndrome after lung transplantation. Proceedings 3rd International Congress on Lung Transplantation, Paris, September 10-11, 1995: 022
    Google Scholar
  • 26 DiGiovine B, Lynch III P J, Martinez F J. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation.  J Immunol . 1996;  157 4194-4202
    PubMedGoogle Scholar
  • 27 Riise G C, Andersson B A, Kjellstrom C. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplantation.  Eur Respir J . 1999;  14 1123-1130
    CrossrefPubMedGoogle Scholar
  • 28 Ward C, Snell G I, Zheng L. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection.  Am J Respir Crit Care Med . 1998;  158 84-91
    PubMedGoogle Scholar
  • 29 Hirsch J, Elssner A, Mazyr G. Bronchiolitis obliterans syndrome after (heart)-lung transplantation: impaired antiprotease defense and increased oxidant activity.  Am J Respir Crit Care Med . 1999;  160 1640-1646
    PubMedGoogle Scholar
  • 30 Behr J, Maier K, Braun B, Schwaiblmair M, Vogelmeier C. Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation.  Transplantation . 2000;  69 1856-1860
    CrossrefPubMedGoogle Scholar
  • 31 McDermott C D, Gavita S M, Shennib H, Giaid A. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis.  Transplantation . 1997;  64 270-274
    PubMedGoogle Scholar
  • 32 Mason N A, Springall D R, Pomerance A, Evans T J, Yacoub M H, Polak J M. Expression of inducible nitric oxide synthase and formation of peroxynitrite in posttransplant obliterative bronchiolitis.  J Heart Lung Transplant . 1998;  17 710-714
    PubMedGoogle Scholar
  • 33 Mauck K A, Hosenpud J D. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation.  J Heart Lung Transplant . 1996;  15 709-714
    PubMedGoogle Scholar
  • 34 Borger P, Kauffman H F, Timmerman J A, Scholma J, van den Berg W J, Koeter G H. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells.  Transplantation . 2000;  69 1408-1413
    PubMedGoogle Scholar
  • 35 Snell G I, Ward C, Wilson J W, Orsida B, Williams T J, Walters E H. Immunopathologic changes in the airways of stable lung transplant recipients.  Thorax . 1997;  52 322-328
    PubMedGoogle Scholar
  • 36 Neuringer I P, Walsh S P, Mannon R B, Gabriel S, Aris R M. Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.  Transplantation . 2000;  69 399-405
    CrossrefPubMedGoogle Scholar
  • 37 Neuringer I P, Mannon R B, Coffman T M. Immune cells in a mouse airway model of obliterative bronchiolitis.  Am J Respir Cell Mol Biol . 1998;  19 379-386
    PubMedGoogle Scholar
  • 38 Hertz M I, Henke C A, Nakhleh R E. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.  Proc Natl Acd Sci USA . 1992;  89 10385-10389
    CrossrefPubMedGoogle Scholar
  • 39 Jonosono M, Fang K C, Keith F M. Measurement of fibroblast proliferative activity in bronchoalveolar lavage fluid in the analysis of obliterative bronchiolitis among lung transplant recipients.  J Heart Lung Transplant . 1999;  18 972-985
    PubMedGoogle Scholar
  • 40 Romanska H M, Ikonen T S, Bishop A E, Morris R E, Polak J M. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease.  J Pathol . 2000;  191 71-77
    PubMedGoogle Scholar
  • 41 Sundaresan S, Mohanakumar T, Smith M A. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.  Transplantation . 1998;  65 648-653
    CrossrefPubMedGoogle Scholar
  • 42 Elssner A, Jaumann F, Dobmann S. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells.  Transplantation . 2000;  70 362-367
    PubMedGoogle Scholar
  • 43 Lee A G, Wagner F M, Giaid A. Immunohistochemical characterization of inflammatory and proliferative events during chronic rejection in rat lung allografts.  Transplantation . 1997;  64 465-471
    PubMedGoogle Scholar
  • 44 El Gamel A, Sim E, Hasleton P. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation.  J Heart Lung Transplant . 1999;  18 828-837
    PubMedGoogle Scholar
  • 45 Charpin J M, Stern M, Grenet D, Israel-Biet D. Insulin-like growth factor-1 in lung transplants with obliterative bronchiolitis.  Am J Respir Crit Care Med . 2000;  161 1991-1998
    CrossrefPubMedGoogle Scholar
  • 46 Glanville A R, Baldwin J C, Burke C M, Theodore J, Robin E D. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression.  Ann Int Med . 1987;  107 300-304
    PubMedGoogle Scholar
  • 47 Van den Berg W J, Geertsma A, van der Bij W. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life.  Am J Respir Crit Care Med . 2000;  161 1937-1941
    PubMedGoogle Scholar
  • 48 Kelly K, Hertz M I. Obliterative bronchiolitis.  Clin Chest Med . 1997;  18 319-337
    CrossrefPubMedGoogle Scholar
  • 49 Pomerance A, Madden B, Burke M M, Yacoub M H. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations.  J Heart Lung Transplant . 1995;  14 761-763
    PubMedGoogle Scholar
  • 50 Kramer M R, Stoehr C, Wang J L. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial biopsies.  J Heart Lung Transplant . 1993;  12 675-681
    PubMedGoogle Scholar
  • 51 Patterson G M, Wilson S, Whang J L. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.  J Heart Lung Transplant . 1996;  15 175-181
    PubMedGoogle Scholar
  • 52 Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation: functional and bronchoalveolar lavage findings.  Am J Respir Crit Care Med . 2000;  161 1924-1929
    CrossrefPubMedGoogle Scholar
  • 53 Maurer J, Estenne M, co-chairs. BOS reclassification. Draft: 2000
    Google Scholar
  • 54 Ikonen T, Kivisaari L, Taskinen E, Piilonen A, Harjula A L. High-resolution CT in long-term follow-up after lung transplantation.  Chest . 1997;  111 370-376
    PubMedGoogle Scholar
  • 55 Estenne M, Van Muylem A, Knoop C, Antoine M. Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution.  Am J Respir Crit Care Med . 2000;  162 1047-1051
    PubMedGoogle Scholar
  • 56 Verleden G M, Dupont L J, Lamont J. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection?.  J Heart Lung Transplant . 1998;  17 231-232
    PubMedGoogle Scholar
  • 57 Fisher A J, Gabbay E, Small T, Doig S, Dark J H, Corris P A. Cross-sectional study of exhaled nitric oxide levels following lung transplantation.  Thorax . 1998;  53 454-458
    PubMedGoogle Scholar
  • 58 Verleden G M, Dupont L, Delcroix M. Exhaled nitric oxide (eNO) and lung transplantation: impact of the native lung?.  Eur Respir J . 2001;  18(suppl 33) 179-180
    PubMedGoogle Scholar
  • 59 Verleden G M, Delcroix M, Buyse B, Dupont L, and the Leuven Lung Transplant Group. Exhaled NO (eNO) after lung transplantation (LTx): a prospective study.  J Heart Lung Transplant . 2001;  20 208
    PubMedGoogle Scholar
  • 60 Valentine V G, Robbins R C, Berry G J. Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis.  J Heart Lung Transplant . 1996;  15 371-383
    PubMedGoogle Scholar
  • 61 Reichenspurner H, Girgis R E, Robbins R C. Obliterative bronchiolitis after lung and heart-lung transplantation.  Ann Thorac Surg . 1995;  60 1845-1853
    CrossrefPubMedGoogle Scholar
      >